3 completed. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Ascariasis: new trials by email Literature Review of Ascariasis trials Research Report on Ascariasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Placebo Moxidectin - Trichuriasis, Ascariasis | Phase 3 | Completed | Jennifer Keiser | 224 | 2024-05-14 | 2025-09-19 |
| Efficacy and Safety of MOX/ALB Co-administration Moxidectin 2 mg Oral Tablet, Albendazole 400 mg Oral Tablet, Ivermectin 3 mg Oral Tablet - Trichuriasis, Ascariasis | Phase 3 | Completed | Jennifer Keiser | 255 | 2021-06-15 | 2024-01-24 |
| Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration moxidectin (8 mg) / albendazole (400 mg), ivermectin (200 µg/kg) / albendazole (400 mg), ALBENDAZOLE 400 Mg ORAL TABLET [ZENTEL] - Trichuriasis, Ascariasis | Phase 2 / Phase 3 | Completed | Jennifer Keiser | 536 | 2021-03-01 | 2024-12-05 |
Ancylostomiasis (3) · Hookworm Infections (3) · Trichuriasis (3) · Helminthiasis (1) · Intestinal Diseases, Parasitic (1)
Adenophorea Infections (3) · Ascaridida Infections (3) · Enoplida Infections (3) · Infections (3) · Nematode Infections (3) · Parasitic Diseases (3) · Secernentea Infections (3) · Strongylida Infections (3) · Helminthiasis (2) · Digestive System Diseases (1) · Gastrointestinal Diseases (1) · Intestinal Diseases (1)
Albendazole (3) · Tablets (3) · moxidectin (3) · Ivermectin (2)
Jennifer Keiser (3)
Tanzania (2) · Côte d’Ivoire (1)